|
|
||||||||||
|
|
|||||||||
Welcome to the Urea Cycle Disorders Consortium!The UCDC exists to bring together physicians and patients for the sake of Urea Cycle Disorders research. We Need Your Help The future of urea cycle disorders research begins here. Every active role a patient takes may possibly play a part in discovering new groundbreaking research and finding new treatments. Research cannot move forward with out your help.
|
UCDC Events | UCDC Publications
4th International Symposium on Urea Cycle Disorders: Catalyzing New Therapeutic Approaches
UCDC Update Newsletter - Spring 2013 ABC News Story: April 26, 2012 - ABC News featured a story on a young man with ASA and chronically high blood pressure. Dr. Brendan Lee’s (Baylor College of Medicine) ASA and nitric oxide research led to a new approach to treat his condition. http://abcnews.go.com/Health/boy-toxic-buildup-breakthrough-treatment/story?id=16213994. Baylor College of Medicine News: November 13, 2011 - 'Moonlighting' enzyme unravels arginine paradox. http://www.bcm.edu/news/item.cfm?newsID=4725Washington Post: November 25, 2010 – Dr. Uta Lichter-Konecki diagnoses girl with UCD. http://www.washingtonpost.com/wp-dyn/content/article/2010/11/24/AR2010112406714.html Washington Post Featured Story: Saving a girl from her own body's poisons Read More > Good Morning America: May 7, 2006 - Mark Batshaw, M.D., Principle Investigator for the Urea Cycle Disorders Consortium and member of the NUCDF Medical Advisory Board, was interviewed by Good Morning America for a segment that aired May 7, 2006. The segment profiled the Rare Diseases Clinical Research Centers, sponsored by the National Institutes of Health. The segment focused on our Urea Cycle Disorders Consortium as an example of this pioneering NIH project.UCDC Web Site en Español! Mira aqui! |
| Glossary | Frequently Asked Questions | Contact Web Master | Accessibility | Disclaimer | Site Map The Urea Cycle Disorders Consortium (UCDC) is a part of NIH Rare Diseases Clinical Research Network (RDCRN). Funding and/or programmatic support for this project has been provided by the National Institute of Child Health and Human Development (NICHD) and the NIH Office of Rare Diseases Research (ORDR). Read Disclaimer > |
|